Short trials OK for shots against variants, Pfizer begins testing in pregnant women and more — 5 updates on the COVID-19 vaccine

Here are five updates on the COVID-19 vaccine over the past week:

Advertisement

1. Most Americans won’t be vaccinated until May or June because the U.S. is getting fewer doses than expected from Johnson & Johnson, Anthony Fauci, MD, said Feb. 16.

2. Pfizer and BioNTech started a large-scale clinical trial to test the COVID-19 vaccine in pregnant women, according to a Feb. 18 announcement.

3. Pfizer’s vaccine was found to be 85 percent effective after a single dose and doesn’t need to be stored at ultralow temperatures, according to a Feb. 19 report.

4. Sanofi and GlaxoSmithKline began a new clinical trial for their protein-based COVID-19 vaccine candidate, according to a Feb. 22 announcement.

5. The FDA said vaccine makers won’t have to conduct monthslong trials to gain authorization for COVID-19 vaccines made to combat variants of the virus, according to a Feb. 22 report.

More articles on surgery centers:
Amazon’s healthcare moves: 7 notes for ASCs and physicians
What ASC management company had the best 2020? & more — 9 ASC industry notes
3 joint-venture ASCs opened or announced in January

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.